Motley Fool Asset Management »

Bridgebio Pharma shares owned by Motley Fool Asset Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Motley Fool Asset Management from 13F filings

Historical chart of Motley Fool Asset Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Motley Fool Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Motley Fool Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $260k 3.4k 76.49

More positions owned by Motley Fool Asset Management

NVIDIA Corp. Ordinary Shares (NVDA)
Alphabet Ordinary Shares (GOOG)
Apple Ordinary Shares (AAPL)
Microsoft Corp. Ordinary Shares (MSFT)
Amazon.com Ordinary Shares (AMZN)
Meta Platforms Ordinary Shares (META)
Broadcom Ordinary Shares (AVGO)
MasterCard Incorporated Ordinary Shares (MA)
Visa Ordinary Shares (V)
Tesla Ordinary Shares (TSLA)
Costco Wholesale Corporation Ordinary Shares (COST)
Walmart Ordinary Shares (WMT)
Netflix Ordinary Shares (NFLX)
Berkshire Hathaway Ordinary Shares (BRK.B)
JPMorgan Chase & Co. Ordinary Shares (JPM)

View all positions for Motley Fool Asset Management

Top funds holding Bridgebio Pharma

Vanguard Group
BlackRock
Viking Global Investors
Kohlberg Kravis Roberts & Co
Farallon Capital Management
Henderson Group
UBS Group
Aisling Capital Management
State Street Corporation
Invesco
Geode Capital Management
Jane Street
Susquehanna International
Frazier Life Sciences Management
Two Sigma Investments

View all funds holding Bridgebio Pharma